Routes of
administration Oral CAS Number 107266-06-8 ChemSpider 54579 | ATC code None PubChem CID 60547 Molar mass 309.38 g/mol | |
 | ||
Legal status In general: uncontrolled | ||
How to pronounce gevotroline
Gevotroline (WY-47,384) is an atypical antipsychotic with a tricyclic structure which was under development for the treatment of schizophrenia by Wyeth-Ayerst. It acts as a balanced, modest affinity D2 and 5-HT2 receptor antagonist and also possesses high affinity for the sigma receptor. It was well-tolerated and showed efficacy in phase II clinical trials but was never marketed.
References
Gevotroline Wikipedia(Text) CC BY-SA